Literature DB >> 10983594

Z-338, a newly synthetized carboxyamide derivative, stimulates gastric motility through enhancing the excitatory neurotransmission.

T Nakajima1, H Nawata, Y Ito.   

Abstract

We studied the effects of Z-338, a newly synthesized carboxyamide derivative, on autonomic neuroeffector transmission in the guinea-pig stomach in relation to its gastrointestinal prokinetic action, by use of tension recording and microelectrode methods. Z-338 (>10(-8) M) dose-dependently enhanced the amplitude of twitch-like contractions and excitatory junction potentials (EJPs) evoked by single or repetitive electrical field stimulation (EFS) without affecting the non-adrenergic non-cholinergic (NANC) relaxation and inhibitory junction potentials (IJPs) in the circular muscle strips of the guinea-pig stomach. Similar to the action of Z 338, pirenzepine (> 10(-8) M), a muscarinic M1-antagonist, enhanced the EJP amplitude, although AF-DX116 (M2-) and 4-DAMP (M3-antagonists) reduced the EJP amplitude, dose-dependently. The EC50 of the Z-338 and pirenzepine concentration response curves on EJPs were 4.7 x 10(-8) M and 1.0 x 10(-8) M, and Hill coefficients were 0.96 and 0.94 respectively. In addition, Z-338 slightly but significantly enhanced the amplitude of slow waves with or without initial spike. These results provide the first evidence that Z-338 exerts its gastrointestinal prokinetic action mainly through enhancing excitatory neuro effector transmission with no effect on NANC inhibitory neuro-effector transmission in the guinea-pig stomach.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10983594     DOI: 10.1540/jsmr.36.69

Source DB:  PubMed          Journal:  J Smooth Muscle Res        ISSN: 0916-8737


  6 in total

1.  What comes after macrolides and other motilin stimulants?

Authors:  J Tack; T Peeters
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

2.  Acotiamide: first global approval.

Authors:  Mary L Nowlan; Mary L Nolan; Lesley J Scott
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

3.  An electrophysiological study of muscarinic and nicotinic receptors of rat paratracheal ganglion neurons and their inhibition by Z-338.

Authors:  Yumiko Kanemoto; Hitoshi Ishibashi; Atsushi Doi; Norio Akaike; Yushi Ito
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

4.  Emerging pharmacological therapy for functional dyspepsia.

Authors:  Mariko Hojo; Akihito Nagahara; Daisuke Asaoka; Sumio Watanabe
Journal:  Clin J Gastroenterol       Date:  2013-09-18

5.  A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia.

Authors:  Kei Matsueda; Michio Hongo; Jan Tack; Youichi Saito; Hiroki Kato
Journal:  Gut       Date:  2011-12-09       Impact factor: 23.059

6.  Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.

Authors:  Hiroshi Yamashita; Akihiko Okada; Kohji Naora; Masafumi Hongoh; Yoshikazu Kinoshita
Journal:  Dig Dis Sci       Date:  2018-11-21       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.